Actively Recruiting
Diabetic Neuropathy in Spinal Cord Stimulator Patients
Led by University of Chicago · Updated on 2026-02-05
25
Participants Needed
1
Research Sites
252 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this study is to assess the effect Spinal Cord Stimulators have toward improving vascular changes of diabetes mellitus in patients eligible for SCS placement based on their condition of painful diabetic neuropathy; we will evaluate improving their disability and quality of life, improving micro-circulatory changes induced by Diabetes Mellitus (DM), improving macro-circulatory changes induced by DM and improving arterial stiffness of the vessels of the lower extremity.
CONDITIONS
Official Title
Diabetic Neuropathy in Spinal Cord Stimulator Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with type 2 diabetes mellitus for more than 1 year
- Diabetes mellitus stage 3 or less
- Age 18 years or older
- Painful diabetic peripheral neuropathy in the lower extremities not responding to treatment
- Ankle Brachial Index less than 0.9
You will not qualify if you...
- Use of anticoagulant medications
- Presence of active infections
- Hemoglobin A1c greater than 10
- Psychiatric disorders or cognitive dysfunctions
- Illicit drug use
- Currently on dialysis
- Body mass index over 35.0
- Surgery within the last 30 days
- Ulcer on the lower extremities
- Calcification of peripheral arteries
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Chicago Medical Center
Chicago, Illinois, United States, 60637
Actively Recruiting
Research Team
M
Magdalena Anitescu, MD, PhD
CONTACT
A
Al McAuley, BS
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here